Clinical trial results

Novartis has long been dedicated to informing the public about the results of its interventional trials for innovative products. Novartis launched the results website in 2005 becoming one of the first companies to publically post results from Phase 2b-4 interventional trials. The Novartis position evolved over time to include public disclosure of results from Phase 1- 2a interventional trials in patients.

Novartis launched the results website in 2005 becoming one of the first companies to publically post results from Phase 2b-4 interventional trials. The Novartis position evolved over time to include public disclosure of results from Phase 1- 2a interventional trials in patients.

Drug development process
Drug development begins and ends with the patient.
Read More
Transparency position
Novartis is committed to the timely registration of trials and posting of results.
Read More
Clinical trial results
Clinical trials are fundamental to the development of innovative products.
Read More

ClinicalTrials.gov

Clinicaltrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.

READ MORE

EU clinical trial registry

The EU Clinical trials register contains information on interventional clinical trials on medicines conducted in the European Union (EU).

READ MORE

This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, visit About cookies page.